Tryptanthrin Inhibits Angiogenesis by Targeting the VEGFR2-Mediated ERK1/2 Signalling Pathway
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tryptanthrin Inhibits Angiogenesis by Targeting the VEGFR2-Mediated ERK1/2 Signalling Pathway
Authors
Keywords
Endothelial cells, Angiogenesis, VEGF signaling, Protein kinase signaling cascade, Cell proliferation, Cytotoxicity assay, ERK signaling cascade, Molecular docking
Journal
PLoS One
Volume 8, Issue 12, Pages e82294
Publisher
Public Library of Science (PLoS)
Online
2013-12-17
DOI
10.1371/journal.pone.0082294
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transport Characteristics of Tryptanthrin and its Inhibitory Effect on P-gp and MRP2 in Caco-2 Cells
- (2016) Xingang Zhu et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Tryptanthrin induces growth inhibition and neuronal differentiation in the human neuroblastoma LA-N-1 cells
- (2013) Xuemei Liao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Anti-angiogenesis therapy in cancer: Current challenges and future perspectives
- (2012) Farbod Shojaei CANCER LETTERS
- Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation
- (2012) Xianmin Mu et al. MOLECULES
- Enzyme kinetic and molecular docking studies for the inhibitions of miltirone on major human cytochrome P450 isozymes
- (2012) Xuelin Zhou et al. PHYTOMEDICINE
- Signal transduction by vascular endothelial growth factor receptors
- (2011) Sina Koch et al. BIOCHEMICAL JOURNAL
- An indirubin derivative, E804, exhibits potent angiosuppressive activity
- (2011) Yuk-Kit Chan et al. BIOCHEMICAL PHARMACOLOGY
- Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy
- (2011) Satoru Takahashi BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Cyclopeptide RA-V inhibits angiogenesis by down-regulating ERK1/2 phosphorylation in HUVEC and HMEC-1 endothelial cells
- (2011) Grace GL Yue et al. BRITISH JOURNAL OF PHARMACOLOGY
- A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis
- (2011) J Kankanala et al. BRITISH JOURNAL OF PHARMACOLOGY
- Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2
- (2011) Li Lai et al. BRITISH JOURNAL OF PHARMACOLOGY
- Polyphyllin D, a steroidal saponin from Paris polyphylla, inhibits endothelial cell functions in vitro and angiogenesis in zebrafish embryos in vivo
- (2011) Judy Yuet-Wa Chan et al. JOURNAL OF ETHNOPHARMACOLOGY
- Modulatory Effects and Action Mechanisms of Tryptanthrin on Murine Myeloid Leukemia Cells
- (2010) Hoi-Ling Chan et al. Cellular & Molecular Immunology
- Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors
- (2010) Kyungik Lee et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Triptolide functions as a potent angiogenesis inhibitor
- (2009) Ming-Fang He et al. INTERNATIONAL JOURNAL OF CANCER
- Anti-inflammatory effects of the extract of indigo naturalis in human neutrophils
- (2009) Yin-Ku Lin et al. JOURNAL OF ETHNOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now